US Patent Issued to ARCUTIS BIOTHERAPEUTICS on June 17 for "Topical roflumilast formulation having antifungal properties" (California, Colorado Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,751, issued on June 17, was assigned to ARCUTIS BIOTHERAPEUTICS INC. (Westlake Village, Calif.).

"Topical roflumilast formulation having antifungal properties" was invented by David Reuben Berk (Westlake Village, Calif.), Patrick Eugene Burnett (Westlake Village, Calif.), Saori Kato (Westlake Village, Calif.) and David W. Osborne (Fort Collins, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to a method of treating a fungal infection comprising administering topically, to a subject in need thereof, an anti-fungal effective amount of roflumilast. Preferably, topically administered roflumilast is used to treat fu...